Article Details

Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD

Retrieved on: 2024-11-18 13:21:34

Tags for this article:

Click the tags to see associated articles and topics

Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD. View article details on hiswai:

Summary

The article discusses denifanstat's promising results in treating MASH, a liver condition linked to diabetes. Tags relate to liver diseases, metabolic disorders, and Sagimet Biosciences' involvement in developing treatments for these interrelated conditions.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up